首页> 外文期刊>Bone marrow transplantation >Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?
【24h】

Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?

机译:与无关的供体进行骨髓移植:鉴定与HLA-A / B / Cw / DRB1 / B3 / B5 / DQB1匹配的供体的可能性是多少?

获取原文
获取原文并翻译 | 示例
       

摘要

Patients transplanted with marrow from an HLA-ABDR serologically matched unrelated donor suffer from more post-transplant complications than those who are transplanted with marrow from an HLA-identical sibling. This is most likely due to either HLA-ABDR incompatibilities not resolved by standard techniques and/or HLA polymorphisms not tested for by routine tissue typing (HLA-Cw,-DQ). By resolving these incompatibilities by molecular techniques combined with the in vitro cytotoxic T lymphocyte precursor frequency (CTLpf) test, we have shown that a high degree of HLA compatibility is associated with increased patient survival. However, higher requirements for HLA matching decrease the number of available donors. We have estimated the probability of finding an HLA-A/B/Cw/DRB1/DRB3/DRB5/DQB1 compatible donor based on 104 consecutive unrelated bone marrow donor searches initiated between January 1995 and December 1997, with December 1998 as the endpoint. For 96 patients (92.3%), one or more ABDR-identical donors were listed in the Bone Marrow Donor Worldwide Registry (BMDW). After contacting the registries, we obtained at least one (mean, 5.36; range, 1-20; total, 461) blood sample for 86 patients. A highly compatible donor was identified for 33/86 patients (38.4%), after testing an average number of 4.5 donors/patients (range, 1-13). However, by accepting an HLA-DRB3 or -DQB1 or -Cw incompatibility, this number would be as high as 68.6%. Approximately half of the patients (n = 40) for whom a search had been initiated have been transplanted: 22 patients with a perfectly matched donor, 15 patients with an HLA-DRB3 or -DQB1 or -Cw mismatch and three with other mismatches. The average time needed to identify the most compatible donor was 4 months. Extremely long searches seemed to be less useful, because after testing the first seven, a more compatible donor was seldom found. These results show that even when requirements for compatibility are high, the chances of finding a donor remain considerably low.
机译:从HLA-ABDR血清学上匹配的无关亲属供体骨髓移植的患者比从HLA相同的同胞骨髓移植的患者遭受更多的移植后并发症。这很可能是由于标准技术无法解决的HLA-ABDR不兼容性和/或常规组织分型(HLA-Cw,-DQ)未测试的HLA多态性。通过分子技术与体外细胞毒性T淋巴细胞前体频率(CTLpf)测试相结合解决这些不兼容问题,我们已经表明,高度的HLA相容性与患者存活率增加相关。但是,对HLA匹配的更高要求会减少可用供体的数量。我们估计了基于1995年1月至1997年12月之间连续进行的104次无关骨髓供体搜索(以1998年12月为终点),找到了HLA-A / B / Cw / DRB1 / DRB3 / DRB5 / DQB1兼容供体的可能性。对于96名患者(92.3%),在骨髓供体全球登记处(BMDW)中列出了一个或多个与ABDR相同的供体。联系注册表后,我们获得了86位患者的至少一份(平均数,5.36;范围:1-20;总数,461)血液样本。在测试平均4.5名捐献者/患者之后(1-13岁),确定了高度相容的捐献者用于33/86位患者(占38.4%)。但是,通过接受HLA-DRB3或-DQB1或-Cw不兼容,该数字将高达68.6%。大约已经开始进行搜索的患者(n = 40)已被移植:22位供体完全匹配的患者,15位HLA-DRB3或-DQB1或-Cw不匹配的患者以及3位其他不匹配的患者。确定最兼容的供体的平均时间为4个月。进行冗长的搜索似乎没有多大用处,因为在测试了前七个之后,很少发现兼容的供体。这些结果表明,即使对兼容性的要求很高,找到供体的机会仍然很低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号